In a decision issued on September 16, 2024, the United States Government Accountability Office (“GAO”) ruled that federal ...

The HHS agency that oversees the 340B drug discount program is threatening Johnson and Johnson with steep fines — and loss of access to Medicare and Medicaid — if it stops giving hospitals upfront ...

The HHS Office of Inspector General has reported that Medicare Advantage plans frequently deny necessary services, causing poor patient outcomes and wasted.

This news of Ozempic price cuts comes on the heels, or tablet, of Novo Nordisk developing a weight loss pill that mirrors the ...

First-of-its-kind research by Tarang Parekh, assistant professor of epidemiology, reviewed the State Innovation Models (SIM), ...

AHA statement on legislative proposals that are to be considered before the Energy and Commerce Committee on Sept. 18.

Medicare Advantage plans have been successful in enrolling Medicare beneficiaries and delivering to those clients. Despite this, some insurers are downsizing their share of the market and hospitals ...

Last year, the Community Oncology Alliance sued to reverse a policy that prohibits oncology practices from mailing cancer ...

South County Hospital officials defending against accusations of mismanagement by a group of doctors have stressed that state ...

Inspections by the state health officials in 2023 documented allegations of a nurse “kissing and touching” a patient’s ...

Keck Hospital of USC has been named a top performer in the 2024 Bernard A. Birnbaum, MD, Quality Leadership award by Vizient, Inc., a leading health care performance improvement company.

The ability to negotiate drug prices is part of a sweeping set of policies in President Joe Biden’s Inflation Reduction Act.